BD’s R&D Pipeline Includes Micro-Needle Drug Delivery; Q4 Sales Up 8%
This article was originally published in The Gray Sheet
Executive Summary
BD is preparing for functionality testing of its development-stage Micro Infuser wearable drug-delivery system, incorporating micro-needles to deliver drugs just below the skin's surface to minimize pain
You may also be interested in...
BD Ups R&D Spending, Focusing On Drug Delivery And Diabetes Research
Becton Dickinson is investing in research on the use of micro-needles and needleless technologies in advanced drug delivery systems
BD Ups R&D Spending, Focusing On Drug Delivery And Diabetes Research
Becton Dickinson is investing in research on the use of micro-needles and needleless technologies in advanced drug delivery systems
BD Logic
Blood glucose meter gains expanded 510(k) clearance for alternate-site testing using blood from the palm and forearm. The expanded clearance also includes BD's Paradigm Link blood glucose meter, co-developed with Medtronic, and "makes palm testing the equivalent to fingertip testing," according to BD...